|
Ultratech Cement Limited (Ultracemco.NS) DCF -Bewertung
IN | Basic Materials | Construction Materials | NSE
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
UltraTech Cement Limited (ULTRACEMCO.NS) Bundle
Entdecken Sie das wahre Potenzial von Ultratech Cement Limited mit unserem DCF-Taschenrechner von Professional Grade! Passen Sie die wichtigsten Annahmen an, erkunden Sie verschiedene Szenarien und bewerten Sie, wie sich Änderungen auf die Bewertung von Ultratech Cement Limited auswirken - alles innerhalb einer einzigen Excel -Vorlage.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 414,759.4 | 442,393.3 | 517,078.5 | 632,399.8 | 709,081.4 | 811,849.8 | 929,512.6 | 1,064,228.4 | 1,218,468.8 | 1,395,063.6 |
| Revenue Growth, % | 0 | 6.66 | 16.88 | 22.3 | 12.13 | 14.49 | 14.49 | 14.49 | 14.49 | 14.49 |
| EBITDA | 98,055.8 | 119,990.4 | 119,396.6 | 110,458.1 | 135,091.9 | 179,213.3 | 205,186.9 | 234,925.0 | 268,973.1 | 307,955.9 |
| EBITDA, % | 23.64 | 27.12 | 23.09 | 17.47 | 19.05 | 22.07 | 22.07 | 22.07 | 22.07 | 22.07 |
| Depreciation | 26,960.7 | 26,657.9 | 27,000.9 | 28,796.3 | 31,658.4 | 43,460.2 | 49,759.0 | 56,970.7 | 65,227.5 | 74,681.0 |
| Depreciation, % | 6.5 | 6.03 | 5.22 | 4.55 | 4.46 | 5.35 | 5.35 | 5.35 | 5.35 | 5.35 |
| EBIT | 71,095.1 | 93,332.5 | 92,395.7 | 81,661.8 | 103,433.5 | 135,753.0 | 155,427.9 | 177,954.4 | 203,745.6 | 233,274.8 |
| EBIT, % | 17.14 | 21.1 | 17.87 | 12.91 | 14.59 | 16.72 | 16.72 | 16.72 | 16.72 | 16.72 |
| Total Cash | 46,511.0 | 131,752.7 | 56,213.8 | 84,200.1 | 60,760.6 | 119,748.6 | 137,104.0 | 156,974.7 | 179,725.4 | 205,773.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 37,340.3 | 45,736.0 | 30,716.1 | 47,401.2 | 42,781.6 | 63,016.3 | 72,149.4 | 82,606.1 | 94,578.4 | 108,285.8 |
| Account Receivables, % | 9 | 10.34 | 5.94 | 7.5 | 6.03 | 7.76 | 7.76 | 7.76 | 7.76 | 7.76 |
| Inventories | 41,483.1 | 40,179.7 | 55,955.8 | 66,118.3 | 83,297.4 | 84,607.7 | 96,870.0 | 110,909.6 | 126,983.9 | 145,387.9 |
| Inventories, % | 10 | 9.08 | 10.82 | 10.46 | 11.75 | 10.42 | 10.42 | 10.42 | 10.42 | 10.42 |
| Accounts Payable | 33,628.9 | 45,482.3 | 58,628.3 | 72,093.0 | 84,783.3 | 86,192.6 | 98,684.6 | 112,987.2 | 129,362.6 | 148,111.3 |
| Accounts Payable, % | 8.11 | 10.28 | 11.34 | 11.4 | 11.96 | 10.62 | 10.62 | 10.62 | 10.62 | 10.62 |
| Capital Expenditure | -17,062.0 | -19,248.7 | -56,134.1 | -62,001.1 | -90,055.9 | -67,911.6 | -77,754.1 | -89,023.2 | -101,925.5 | -116,697.7 |
| Capital Expenditure, % | -4.11 | -4.35 | -10.86 | -9.8 | -12.7 | -8.37 | -8.37 | -8.37 | -8.37 | -8.37 |
| Tax Rate, % | 25.65 | 25.65 | 25.65 | 25.65 | 25.65 | 25.65 | 25.65 | 25.65 | 25.65 | 25.65 |
| EBITAT | 78,051.8 | 64,890.3 | 81,127.5 | 55,760.3 | 76,898.2 | 108,591.0 | 124,329.3 | 142,348.5 | 162,979.3 | 186,600.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 42,756.0 | 77,060.6 | 64,384.1 | 9,172.6 | 18,631.5 | 64,003.9 | 87,430.8 | 100,102.2 | 114,610.2 | 131,220.9 |
| WACC, % | 7.36 | 7.27 | 7.32 | 7.27 | 7.28 | 7.3 | 7.3 | 7.3 | 7.3 | 7.3 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 395,336.6 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 136,470 | |||||||||
| Terminal Value | 4,135,282 | |||||||||
| Present Terminal Value | 2,907,394 | |||||||||
| Enterprise Value | 3,302,731 | |||||||||
| Net Debt | 108,494 | |||||||||
| Equity Value | 3,194,237 | |||||||||
| Diluted Shares Outstanding, MM | 288 | |||||||||
| Equity Value Per Share | 11,074.57 |
What You Will Receive
- Adjustable Forecast Inputs: Effortlessly modify key assumptions (growth %, margins, WACC) to create various scenarios.
- Pre-Filled Industry Data: UltraTech Cement Limited’s financial information provided to streamline your analysis.
- Automated DCF Calculations: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Sleek: A professional Excel model tailored to meet your valuation requirements.
- Designed for Analysts and Investors: Perfect for exploring projections, verifying strategies, and enhancing efficiency.
Key Features
- Genuine ULTRACEMCONS Data: Pre-loaded with UltraTech Cement's historical financial figures and future projections.
- Comprehensive Customization Options: Tailor revenue growth, profit margins, WACC, tax rates, and capital expenditures to fit your analysis.
- Adaptive Valuation Framework: Real-time updates to Net Present Value (NPV) and intrinsic value according to your specified inputs.
- Scenario Analysis: Develop various forecasting scenarios to explore different valuation results.
- Intuitive User Interface: Designed for ease of use, suitable for both professionals and novices.
How It Works
- Step 1: Download the prebuilt Excel template featuring UltraTech Cement Limited’s (ULTRACEMCONS) data.
- Step 2: Navigate through the pre-filled sheets to grasp the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly view the updated results, including UltraTech Cement Limited’s intrinsic value.
- Step 5: Make well-informed investment choices or generate reports based on the results.
Why Choose the UltraTech Cement Calculator?
- Accuracy: Reliable data driven by real UltraTech financials ensures precision.
- Flexibility: Users can effortlessly test and adjust inputs to suit their needs.
- Time-Saving: Eliminate the complexities of creating a DCF model from the ground up.
- Professional-Grade: Crafted with the expertise and attention to detail expected by CFOs.
- User-Friendly: Simplified interface designed for those without extensive financial modeling skills.
Who Should Use This Product?
- Individual Investors: Make informed choices regarding the purchase or sale of UltraTech Cement Limited (ULTRACEMCONS) shares.
- Financial Analysts: Enhance valuation processes with easily accessible financial models for UltraTech Cement Limited (ULTRACEMCONS).
- Consultants: Provide professional valuation insights for UltraTech Cement Limited (ULTRACEMCONS) to clients efficiently and accurately.
- Business Owners: Gain an understanding of how major firms like UltraTech Cement Limited (ULTRACEMCONS) are valued to inform your strategic decisions.
- Finance Students: Master valuation approaches using real-world data and case studies focused on UltraTech Cement Limited (ULTRACEMCONS).
Contents of the Template
- Preloaded ULTRACEMCONS Data: Historical and projected financial metrics, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade spreadsheets for determining intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for modifying revenue growth, tax rates, and discount rates.
- Financial Statements: Detailed annual and quarterly financial statements for comprehensive analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios for performance evaluation.
- Dashboard and Charts: Visual summaries of valuation results and underlying assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.